Symptomatic remission with paliperidone palmitate 3-monthly formulation in schizophrenia patients in a clinical practice setting

dc.contributor.author	García-Portilla González, María Paz
dc.contributor.author	Llorca, P. M.
dc.contributor.author	Maina, G.
dc.contributor.author	Bozikas, V. P.
dc.contributor.author	Devrimci Ozguven, H.
dc.contributor.author	Kim, S. W.
dc.contributor.author	Bergmans, P.
dc.contributor.author	Usankova, I.
dc.contributor.author	Cherubin, P.
dc.contributor.author	Najarian, D.
dc.contributor.author	Pungor, K.
dc.date.accessioned	2019-08-21T07:34:16Z
dc.date.available	2019-08-21T07:34:16Z
dc.date.issued	2019
dc.identifier.issn	0586-7614
dc.identifier.issn	1745-1701
dc.identifier.uri	http://hdl.handle.net/10651/52298
dc.description	Congress of the Schizophrenia International Research Society (2019, Orlando, Florida, USA)
dc.format.extent	p. S295-
dc.language.iso	eng
dc.relation.ispartof	Schizophrenia Bulletin, 45(S2)
dc.rights	© 2019 García-Portilla González et al.
dc.source	WOS:000466725400491
dc.title	Symptomatic remission with paliperidone palmitate 3-monthly formulation in schizophrenia patients in a clinical practice setting
dc.type	conference output	spa
dc.identifier.doi	10.1093/schbul/sbz018.522
dc.relation.publisherversion	http://dx.doi.org/10.1093/schbul/sbz018.522

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.